Low-dose vaccination against hepatitis B
β
Mr. Alexander Milne; Mary Dimitrakakis; Carolyn Campbell; Ron Lucas; Geoff Allwo
π
Article
π
1987
π
John Wiley and Sons
π
English
β 321 KB
Six hundred forty-three children, negative for markers of hepatitis B virus (HBV) infections, were given three X 2-micrograms doses of Merck, Sharp and Dohme (MSD) plasma derived hepatitis B vaccine (H-B-Vax) at monthly intervals. Twelve months after the first dose of vaccine, antibody to hepatitis